Gordon Campbell | Parliament TV | Parliament Today | News Video | Crime | Employers | Housing | Immigration | Legal | Local Govt. | Maori | Welfare | Unions | Youth | Search


Tracking survey: Support lifts for personal cannabis use

Tracking survey: Support lifts for personal cannabis use

Support for legalising personal cannabis use has risen by 9% in the past quarter, according to the country’s only 12-month tracking survey on how New Zealanders would vote in the Government's binding referendum next year.

The large November survey marks the fourth in a series of independent surveys tracking nationwide opinion on cannabis law reform. Commissioned by leading New Zealand medicinal cannabis company, Helius Therapeutics, the four surveys have been conducted by Horizon Research.

Paul Manning, Co-Chief Executive of Helius Therapeutics, says Horizon’s tracking of public opinion over the past 12 months, using the same methodology, makes it New Zealand’s most significant series of surveys on the referendum so far.

“The result shows a definite lift in public support following a slump over winter, and there’ll be plenty of speculation as to why. Factors could include September’s release of the Helen Clark Foundation’s report titled ‘The case for YES’, the hit documentary series ‘Patrick Gower: On Weed’, and perhaps a reduction in scaremongering by conservative groups, for now,” says Mr Manning.

The latest survey of 1,199 adult New Zealanders shows support has risen to 48%, from 39% recorded in August. Support in April was at 52%, while 12 months ago, in November 2018, it was at 60%.

“Back in August, it seemed the referendum was heading for defeat. I’m not so sure now. A lot of support from middle-aged Kiwis has returned, with Labour and Greens’ voters also now clearly swinging in behind. The reality is, who turns out on election day will ultimately decide the referendum result. Whether younger Kiwis will vote in higher numbers than in the past, remains a big unknown,” he says.

The survey reveals the number of those against legalising the personal use of cannabis has fallen to 38% - down 9% from 47% in August. Those with no opinion remains steady at 14%.

The number of Green Party voters in favour is bouncing back, from 64% in August to 73% this month. Labour Party supporters in favour have also notably risen, from 46% in August to 60%.

At the same time nearly two-thirds of National Party supporters remain against legalising cannabis for personal use. In August 64% of National voters were against, now lifting slightly to 65%.

“The issue is now being driven by party voting allegiances: it's increasingly a partisan battle,” says Mr Manning.

For all age groups between 35 and 64 years of age, support has returned significantly since August. In the youngest demographic group support has lifted, while in the oldest, support has consistently tracked down, now dropping to its lowest recorded level.

For 18 to 24-year-olds support has risen from 56% in August to 61% in November; for 25 to 34-year-olds support has fallen from 50% to 46%; for 35 to 44-year olds support has risen from 33% to 54%; for 45 to 54-year olds support has risen from 39% to 63%; for 55 to 64-year olds support has risen from 27% to 54%; for 65 to 74-year olds support has fallen from 35% to 31%; and for 75 years or over support has fallen from 24% to 16%.

Support between men and women has become less balanced, with male support up 14% since August. At 53%, a majority of New Zealand men now favour legalising cannabis for personal use, up from 39%. Female support has risen to 42%, up from 40%. Notably 18% of women remain undecided.

Mr Manning says wherever Kiwis sit on the personal use of cannabis, there is merit in regulation. It would take recreational cannabis away from a gang-controlled black market and free over 320,000 everyday Kiwis from breaking the law. Significant tax revenue, employment opportunities, and control quality standards could also be achieved.

“Helius is solely focused on medicinal cannabis, but without doubt legalising personal use would enable the creation of a wider variety of cannabis-based wellness products. These could include over-the-counter health supplements and cosmetics.”

He believes New Zealand cannabis proponents will be boosted by a United States landmark decision on cannabis reform. Recently, the House Judiciary Committee voted to approve a bill which would effectively put an end to cannabis prohibition on a federal level, removing it from the Controlled Substances Act.

Commissioned by Helius Therapeutics and carried out independently by Horizon Research, the results are from of a series of nationwide online surveys of adults representing the 18+ population at the last census. The most recent survey of 1,199 respondents was conducted between 11 to 17 November 2019. Respondents were members of Horizon’s national panels and a third-party nationwide research panel. Results are weighted by age, gender and party voted for at the 2017 general election. At a 95% confidence level, the maximum margin of error is ±3.1%.

Key results:

At this time, do you think you will vote for or against legalising cannabis for personal use in New Zealand?
All respondents:
• 48% for
• 38% against
• 14% have no opinion

Male – 53% for
Female – 42% for

Age Group:
• 18 – 24 years: 61% for
• 25 – 34 years: 46% for
• 35 – 44 years: 54% for
• 45 – 54 years: 63% for
• 55 – 64 years: 54% for
• 65 – 74 years: 31% for
• 75yrs or over: 16% for

Party Vote 2017:
• ACT: 42% for/ 58% against
• Green: 73% for / 20% against
• Labour: 60% for / 31% against
• National: 24% for / 65% against
• NZ First: 36% for / 55% against


Link to: Tracking Survey - Cannabis Referendum Support – Twelve months from Nov 2018 to Nov 2019, conducted by Horizon Research and commissioned by Helius Therapeutics.

© Scoop Media

Parliament Headlines | Politics Headlines | Regional Headlines

RNZ Live Blog: Eruption At Whakaari / White Island

An eruption has occured on Whakaari / White Island in the Eastern Bay of Plenty, sending a huge plume of smoke and ash into the sky.More>>

Police Update: Five Confirmed Dead - Eight People Unaccounted For
Work has continued overnight to respond to the eruption on White Island. Enquiries with tour operators indicate that 47 people were on White Island at the time of the eruption. Police can now advise that in addition to the five people confirmed deceased, eight people remain unaccounted for following the eruption. More>>


Big, Bold, Permanent Change Needed: Children's Commissioner On 2019 Child Poverty Monitor

“I want to see family incomes dramatically raised by increasing benefits and making the minimum wage a living wage. And the Government needs to move much faster at increasing the supply of social housing..." More>>


RNZ Live Updates: Weather Mayhem Strands Tourists; Major Roads Closed

Hundreds of tourists are stranded on the West Coast, and on the other side of the South Island a flood-damaged bridge has closed State Highway 1, after a weekend of torrential rain... More>>


Policing: Armoured Specialist Police Vehicles

New Zealand Police has taken delivery of three Armoured Special Purpose Vehicles. The vehicles are unmarked and look like standard Toyota Land cruisers... They will not be used for patrol. More>>

Single Use PVC And Polystyrene Out: Next Steps On Plastic Waste

The Government will phase out more single-use plastics following the success of its single-use plastic bag ban earlier this year and the release today of a pivotal report for dealing with waste. More>>


Faafoi Statement: Minister's Suspicious Immigration Texts

I have apologised to the Prime Minister and understand I have let her down in regards to my dealings with Jason Kerrison over an immigration matter concerning his family. More>>


NZ First Conflicts Of Interest: New Details Around Timeline

New information has emerged showing it was the New Zealand First chief of staff who identified potential conflicts of interest between a forestry company and two senior government ministers, sparking a series of declarations. More>>



Five New Cancer Meds In Six Months: Pharmac Funds More Cancer Medicines, Faster Assessment

PHARMAC has confirmed that two new medicines – olaparib for ovarian cancer and fulvestrant for breast cancer – have been approved for funding... Rituximab and bortezomib, which are already funded, have also been approved for widened access following successful commercial proposals from new suppliers. More>>






InfoPages News Channels